Xencor, Inc.
NASDAQ:XNCRBiotechnology
-$0.13 today
- Market cap
- $2.58B
- Beta
- 0.93
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$2.29
Volume 0.87M
Average 0.80M
XNCR Sales of Investments
Cash received from selling or redeeming investments.
Xencor, Inc.NASDAQ: XNCR
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments declines year over year
Q2 FY2026 sales of investments of $85.66M fell 21.0% year over year, behind the -16.6% change in trailing-twelve-month sales of investments. Sequentially, it fell 14.3% from the prior quarter. Over 3 fiscal years it compounded at +11.7% a year.
Context
- Sales of investments amounted to 340.5% of revenue in FY2025, down 199.5 pp from a year earlier.
- Sales of investments increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -21.0% toward the trailing-twelve-month pace of -16.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 427.64M USD
- Year-over-year change
- -28.3%
- 4-year CAGR
- -3.1%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 427.64M | -28.3% |
| FY2024 | 2024-12-31 | 596.66M | -13.9% |
| FY2023 | 2023-12-31 | 693.09M | +126.1% |
| FY2022 | 2022-12-31 | 306.61M | -36.8% |
| FY2021 | 2021-12-31 | 485.15M | — |
Sales of Investments vs competitors
How XNCR compares with its peers on the latest reported figures
- Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -16.6% is the 6th highest of 7, against a peer median of +21.4%.
- Sales of investments amounts to 367.2% of revenue for XNCR, versus a peer median of 64.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.03B USD | — | -28.7% | 49.1% | |
| LTM Aug 2026 | $614.95M USD | +3.0% | +30.4% | 87.6% | |
| LTM Sep 2026 | $502.67M USD | -21.3% | +28.6% | 448811.6% | |
| LTM Jun 2026 | $385.46M USD | -16.6% | +11.7% | 367.2% | |
| LTM Jun 2026 | $384.71M USD | +43.5% | -29.9% | 704.7% | |
| LTM Mar 2026 | $125.44M USD | -4.7% | -21.0% | 79.9% | |
| LTM Mar 2026 | $13.99M USD | +39.9% | — | 3.6% | |
| FY2025 | €13.51M EUR | +40.9% | +65.2% | 484.9% | |
| LTM Dec 2025 | $0 USD | — | +3.4% | 0.0% | |
| LTM Jun 2024 | $0 USD | — | — | 0.0% | |
| FY2025 | A$0 AUD | — | — | 0.0% | |
| Peer median (excluding XNCR) | — | +21.4% | +3.4% | 64.5% | |
Competitors are the stored peer set for XNCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 82.63M | (55.18M) | (133.13M) | (236.54M) | (91.92M) |
| Depreciation & Amortization | 7.49M | 8.8M | 11.5M | 12.11M | 10.51M |
| Deferred Income Tax | (18.97M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 36.98M | 48.91M | 0 | 53.28M | 43.23M |
| Change in Working Capital | (102.6M) | 48.87M | 19.13M | (40.4M) | 47.45M |
| Accounts Receivables | (54.94M) | 36.86M | 19.83M | (32.67M) | 28.73M |
| Inventory | 1.4M | 0 | 0 | 0 | 0 |
| Accounts Payables | 5.05M | (3.91M) | 3.83M | 2.85M | (3.95M) |
| Other Working Capital | (54.11M) | 15.92M | (4.53M) | (10.57M) | 22.67M |
| Other Non-Cash Items | (22.38M) | (26.91M) | 24.58M | 9.36M | (144.39M) |
| Operating Cash Flow | (16.85M) | 24.49M | (77.93M) | (202.19M) | (135.12M) |
| Capital Expenditures | (15.98M) | (43.4M) | (18.45M) | (6.1M) | (3.15M) |
| Acquisitions (Net) | (2.66M) | 0 | 501K | 0 | 0 |
| Purchases of Investments | (509.6M) | (387.93M) | (782.91M) | (595.05M) | (298.9M) |
| Sales of Investments | 485.15M | 306.61M | 693.09M | 596.66M | 427.64M |
| Other Investing Activities | (3.16M) | 90K | 0 | (3.38M) | 14.39M |
| Investing Cash Flow | (46.25M) | (119.73M) | (110.57M) | (7.87M) | 139.99M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 28.92M | 0 | 5.39M | 201.26M | 9.96M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 14.12M | 5.7M | 183.33M | (4.1M) | (1.73M) |
| Financing Cash Flow | 43.04M | 5.7M | 188.72M | 197.15M | 8.23M |
| Effect of Forex Changes | 0 | 0 | (380K) | 0 | 0 |
| Net Change in Cash | (20.06M) | (89.54M) | (152K) | (12.91M) | 13.1M |
| Free Cash Flow | (32.83M) | (18.92M) | (96.37M) | (208.29M) | (138.27M) |
Xencor, Inc.
NASDAQ:XNCR
Intrinsic Alpha fair value
Locked
Current Price
$34.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.